These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 10850810

  • 1. Characterization of an anti-Borrelia burgdorferi OspA conformational epitope by limited proteolysis of monoclonal antibody-bound antigen and mass spectrometric peptide mapping.
    Legros V, Jolivet-Reynaud C, Battail-Poirot N, Saint-Pierre C, Forest E.
    Protein Sci; 2000 May; 9(5):1002-10. PubMed ID: 10850810
    [Abstract] [Full Text] [Related]

  • 2. Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA.
    Koide S, Yang X, Huang X, Dunn JJ, Luft BJ.
    J Mol Biol; 2005 Jul 08; 350(2):290-9. PubMed ID: 15935380
    [Abstract] [Full Text] [Related]

  • 3. Structural identification of a key protective B-cell epitope in Lyme disease antigen OspA.
    Ding W, Huang X, Yang X, Dunn JJ, Luft BJ, Koide S, Lawson CL.
    J Mol Biol; 2000 Oct 06; 302(5):1153-64. PubMed ID: 11183781
    [Abstract] [Full Text] [Related]

  • 4. Identification of a Borrelia burgdorferi OspA T cell epitope that promotes anti-OspA IgG in mice.
    Bockenstedt LK, Fikrig E, Barthold SW, Flavell RA, Kantor FS.
    J Immunol; 1996 Dec 15; 157(12):5496-502. PubMed ID: 8955199
    [Abstract] [Full Text] [Related]

  • 5. Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A lyme disease vaccination.
    Molloy PJ, Berardi VP, Persing DH, Sigal LH.
    Clin Infect Dis; 2000 Jul 15; 31(1):42-7. PubMed ID: 10913394
    [Abstract] [Full Text] [Related]

  • 6. NMR identification of epitopes of Lyme disease antigen OspA to monoclonal antibodies.
    Huang X, Yang X, Luft BJ, Koide S.
    J Mol Biol; 1998 Aug 07; 281(1):61-7. PubMed ID: 9680475
    [Abstract] [Full Text] [Related]

  • 7. Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis.
    Fawcett PT, Rose CD, Budd SM, Gibney KM.
    Clin Diagn Lab Immunol; 2001 Jan 07; 8(1):79-84. PubMed ID: 11139199
    [Abstract] [Full Text] [Related]

  • 8. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease.
    Wallich R, Siebers A, Jahraus O, Brenner C, Stehle T, Simon MM.
    Infect Immun; 2001 Apr 07; 69(4):2130-6. PubMed ID: 11254567
    [Abstract] [Full Text] [Related]

  • 9. A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula.
    Nassal M, Skamel C, Kratz PA, Wallich R, Stehle T, Simon MM.
    Eur J Immunol; 2005 Feb 07; 35(2):655-65. PubMed ID: 15668917
    [Abstract] [Full Text] [Related]

  • 10. Crystallization and preliminary X-ray analysis of Borrelia burgdorferi outer surface protein A (OspA) complexed with a murine monoclonal antibody Fab fragment.
    Li H, Lawson CL.
    J Struct Biol; 1995 Feb 07; 115(3):335-7. PubMed ID: 8573475
    [Abstract] [Full Text] [Related]

  • 11. Approaches toward the directed design of a vaccine against Borrelia burgdorferi.
    Luft BJ, Dunn JJ, Lawson CL.
    J Infect Dis; 2002 Feb 15; 185 Suppl 1():S46-51. PubMed ID: 11865439
    [Abstract] [Full Text] [Related]

  • 12. Association of antibiotic treatment-resistant Lyme arthritis with T cell responses to dominant epitopes of outer surface protein A of Borrelia burgdorferi.
    Chen J, Field JA, Glickstein L, Molloy PJ, Huber BT, Steere AC.
    Arthritis Rheum; 1999 Sep 15; 42(9):1813-22. PubMed ID: 10513794
    [Abstract] [Full Text] [Related]

  • 13. Dogs vaccinated with common Lyme disease vaccines do not respond to IR6, the conserved immunodominant region of the VlsE surface protein of Borrelia burgdorferi.
    O'Connor TP, Esty KJ, Hanscom JL, Shields P, Philipp MT.
    Clin Diagn Lab Immunol; 2004 May 15; 11(3):458-62. PubMed ID: 15138170
    [Abstract] [Full Text] [Related]

  • 14. The hamster immune response to tick-transmitted Borrelia burgdorferi differs from the response to needle-inoculated, cultured organisms.
    Roehrig JT, Piesman J, Hunt AR, Keen MG, Happ CM, Johnson BJ.
    J Immunol; 1992 Dec 01; 149(11):3648-53. PubMed ID: 1431134
    [Abstract] [Full Text] [Related]

  • 15. Molecular characterization of the OspA(161-175) T cell epitope associated with treatment-resistant Lyme arthritis: differences among the three pathogenic species of Borrelia burgdorferi sensu lato.
    Drouin EE, Glickstein LJ, Steere AC.
    J Autoimmun; 2004 Nov 01; 23(3):281-92. PubMed ID: 15501399
    [Abstract] [Full Text] [Related]

  • 16. Formation of the single-layer beta-sheet of Borrelia burgdorferi OspA in the absence of the C-terminal capping globular domain.
    Huang X, Nakagawa T, Tamura A, Link K, Koide A, Koide S.
    J Mol Biol; 2001 Apr 27; 308(2):367-75. PubMed ID: 11327773
    [Abstract] [Full Text] [Related]

  • 17. A murine IgG1 monoclonal antibody that binds specifically to outer surface protein A of Lyme disease spirochete Borrelia burgdorferi.
    Abolhassani M, Pavia CS, Dunn JJ, Chiao JW.
    FEMS Microbiol Lett; 1993 May 15; 109(2-3):303-9. PubMed ID: 8339920
    [Abstract] [Full Text] [Related]

  • 18. Analysis of the lipidated recombinant outer surface protein A from Borrelia burgdorferi by mass spectrometry.
    Bouchon B, Klein M, Bischoff R, Van Dorsselaer A, Roitsch C.
    Anal Biochem; 1997 Mar 01; 246(1):52-61. PubMed ID: 9056182
    [Abstract] [Full Text] [Related]

  • 19. Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development.
    Izac JR, Oliver LD, Earnhart CG, Marconi RT.
    Vaccine; 2017 May 31; 35(24):3178-3185. PubMed ID: 28479174
    [Abstract] [Full Text] [Related]

  • 20. Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.
    Lovrich SD, Jobe DA, Schell RF, Callister SM.
    Clin Diagn Lab Immunol; 2005 Jun 31; 12(6):746-51. PubMed ID: 15939749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.